Details of the Drug Formulaction

General Information of Drug Formulation (ID: F12077)

• Formulation Name: Lisdexamfetamine 30 mg capsule
• Company: Shire

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Lisdexamfetamine	(DM6W8V5)	Attention deficit hyperactivity disorder	6A05.Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
FD&C red no. 3	(E00629)	Not Available	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Sunset yellow FCF	(E00255)	17730	Colorant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent